J Wikstrand
Overview
Explore the profile of J Wikstrand including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
172
Citations
1891
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Batty J, Hall A, White H, Wikstrand J, de Boer R, van Veldhuisen D, et al.
Clin Pharmacol Ther
. 2013 Nov;
95(3):321-30.
PMID: 24193112
To explore the pharmacogenetic effects of the cytochrome P450 (CYP)2D6 genotype in patients with systolic heart failure treated using controlled/extended-release (CR/XL) metoprolol, this study assessed the CYP2D6 locus for the...
2.
Wikstrand J, Wedel H, Castagno D, McMurray J
J Intern Med
. 2013 Oct;
275(2):134-43.
PMID: 24118421
Aims: The four pivotal beta-blocker trials in heart failure (HF) had different inclusion criteria, making comparison difficult without patient stratifying. The aim of this study was to compare, in similar...
3.
Nymo S, Ueland T, Askevold E, Flo T, Kjekshus J, Hulthe J, et al.
J Intern Med
. 2012 Jan;
271(5):436-43.
PMID: 22211640
Objective: To study the prognostic value of neutrophil gelatinase-associated lipocalin (NGAL) in chronic heart failure (HF) of ischaemic aetiology. Background: Neutrophil gelatinase-associated lipocalin is a marker of kidney injury as...
4.
Schmidt C, Wikstrand J
Atherosclerosis
. 2009 Jan;
205(1):284-9.
PMID: 19124125
Objectives: The aim of the present study was to investigate the relationship between atherosclerotic progression rate as measured by carotid artery IMT during very long-term follow-up in clinically healthy men...
5.
Brohall G, Schmidt C, Behre C, Hulthe J, Wikstrand J, Fagerberg B
Nutr Metab Cardiovasc Dis
. 2008 Dec;
19(5):327-33.
PMID: 19097767
Background And Aims: Impaired glucose tolerance (IGT) is regarded as a transient metabolic state leading to type-2 diabetes, and is known to predict future risk of cardiovascular disease. This study...
6.
Sigurdardottir V, Fagerberg B, Wikstrand J, Schmidt C, Hulthe J
Scand J Clin Lab Invest
. 2008 Jul;
68(4):292-7.
PMID: 18612920
Objective: The aim of this study was to elucidate the relationship between the echogenicity of carotid artery plaques and the following risk factors: circulating oxLDL, hsCRP, the metabolic syndrome (MetS),...
7.
Behre C, Brohall G, Hulthe J, Wikstrand J, Fagerberg B
J Intern Med
. 2006 Aug;
260(3):238-44.
PMID: 16918821
Objective: To examine whether serum adiponectin concentrations were associated with subclinical atherosclerosis assessed as intima media thickness (IMT) in the carotid arteries in Caucasian women with varying degrees of glucose...
8.
Schmidt C, Fagerberg B, Wikstrand J, Hulthe J
Atherosclerosis
. 2005 Dec;
189(1):178-85.
PMID: 16384562
Objectives: The aim of the present study was to investigate the association between serum concentrations of apoB, apoA-I and the apoB/apoA-I ratio and future cardiovascular events in a group of...
9.
Wallenfeldt K, Fagerberg B, Wikstrand J, Hulthe J
J Intern Med
. 2004 Oct;
256(5):413-20.
PMID: 15485477
Objective: To investigate the association between plasma oxidized low-density lipoprotein (OxLDL) and the progress of clinically silent atherosclerosis, as measured by ultrasound in the carotid arteries. Design: Prospective, observational study...
10.
Wikstrand J, Fagerberg B, Goldstein S, Kjekshus J, Wedel H
Lancet
. 2003 Oct;
362(9389):1076-7.
PMID: 14522542
No abstract available.